Middletown, DE – June 30, 2014 – (Techsonian) – Advanced Cell Technology, (OTCMKTS:ACTC), a biotechnology company, involves in the development and commercialization of human embryonic and adult stem cell technology in the field of regenerative medicine. The company is conducting various clinical trials for treating macular degeneration, and has a preclinical development pipeline focused on products for eye diseases, autoimmune and inflammatory diseases, and wound healing.
Advanced Cell Technology, Inc. (OTCMKTS:ACTC) increased 0.31% at the price of $0.0650 recently on a traded volume of 4.53 million shares, in comparison to 11.27 million shares of average trading volume. The company has a total market capitalization of $181.94 million.
Will ACTC Continue To Move Higher? Find Out Here
Nuvilex, (OTCQB:NVLX),can accomplish more in its upcoming preclinical trials than many may realize. With the declaration that Translational Drug Development will be conducting the preclinical studies and clinical trials that will follow to study the Maryland biotech’s pancreatic cancer treatment and its ability to relieve symptoms associated with the deadly cancer, Nuvilex entered into a high profile opportunity.
Nuvilex Inc (OTCMKTS:NVLX) plunged -2.09% at the trading price of $0.258 on a traded volume of 605,859 shares till now, whereas its average trading volume is 2.06 million shares. The Intra-day range for the stock is $0.26 and $0.26.The company has a total market capitalization of $164.68 million.
Has NVLX Found The Bottom and Ready To Move Up? Find Out Here
BASF SE, (OTCMKTS:BASFY), operates as a chemical company worldwide. The company operates in five segments: Chemicals, Performance Products, Functional Materials and Solutions, Agricultural Solutions, and Oil and Gas.
BASF SE (ADR) (OTCMKTS:BASFY) jumped 0.71% at $116.43 recently. The 52-week range for the stock is $86.00 and $119.71. Its introductory price for the day was $116.22, with the overall traded volume of 21,533 shares.
For How Long BASFY Gloss will Attract Investors? Find out via this report
HyperSolar Inc (OTCMKTS:HYSR) announced that its patent pending polymer coating, when applied to a bromine electrode in a wireless solar powered particle, resulted in 170 continuous hours of hydrogen production, one of the longest duration applications of wireless hydrogen production on record.
HyperSolar Inc (OTCMKTS:HYSR) after opening its shares at the price of $0.03, dropped -0.34%, its recent trading price was $0.0.289 for the day. The stock moved on a traded volume of 5.79 million shares, in comparison to 2.99 million shares of average trading volume.
The 52-week range for the stock is $0.01 and $0.13.
Will HYSR Get Buyers Even After The Recent Rally? Find Out Here
This entry passed through the Full-Text RSS service — if this is your content and you’re reading it on someone else’s site, please read the FAQ at fivefilters.org/content-only/faq.php#publishers.